Upregulation of extrinsic and intrinsic apoptosis pathways in head and neck squamous cells by promotion of caspase activation by P13K inhibitor HCD – A systematic review.

Dr. Karthik  Shunmugavelu; Dr. Parthiban  Nallaiyan (M.D.S); Uma Bharathi  S

doi:10.51168/sjhrafrica.v7i3.2481

Authors

Dr. Karthik Shunmugavelu Assistant Professor, Department of Dentistry, PSP Medical College Hospital and Research Institute, Tambaram, Kanchipuram main roadOragadam Panruti, Kanchipuram district Tamilnadu 631604 India
Dr. Parthiban Nallaiyan (M.D.S) Assistant Professor, Government Medical College and Hospital, The Nilgiris.Tamilnadu India
Uma Bharathi S Undergraduate, PSP Medical College Hospital and research institute, Tambaram, Kanchipuram main roadOragadam Panruti, Kanchipuram district Tamilnadu 631604 India

DOI:

https://doi.org/10.51168/sjhrafrica.v7i3.2481

Keywords:

Head and neck squamous cell carcinoma, Oral squamous cell carcinoma, PI3K/Akt signaling pathway, 16-Hydroxycleroda-3, 13-dien-15,16-olide, HCD, Apoptosis, Intrinsic pathway, Extrinsic pathway, Caspase activation, Polyalthia longifolia.

Abstract

Background

Constitutive activation of the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) pathway promotes tumor cell survival and resistance to apoptosis in head and neck squamous cell carcinoma (HNSCC). 16-Hydroxycleroda-3,13-dien-15,16-olide (HCD), a clerodane diterpene isolated from Polyalthia longifolia, has demonstrated pro-apoptotic activity through inhibition of PI3K signaling. This systematic review evaluated whether HCD activates intrinsic and extrinsic apoptotic pathways through caspase signaling in HNSCC models.

Methods

A systematic review was conducted according to PRISMA 2020 guidelines. PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched using predefined Boolean combinations related to HCD, PI3K inhibition, and apoptosis. Two reviewers independently screened studies and extracted data. Eligible studies were original experimental investigations evaluating apoptosis-related endpoints, including caspase activation, Bax/Bcl-2 modulation, cytochrome-c release, PARP cleavage, reactive oxygen species generation, and PI3K/Akt signaling alterations. Due to heterogeneity in experimental models and outcome reporting, findings were synthesized using structured qualitative narrative analysis.

Results

Five in vitro studies met the inclusion criteria. HCD consistently reduced PI3K/Akt phosphorylation, increased oxidative stress, altered Bax/Bcl-2 balance, induced mitochondrial membrane depolarization, and activated caspase-9 and caspase-3. In oral squamous cell carcinoma models, activation of caspase-8 and upregulation of death receptor signaling indicated concurrent engagement of extrinsic apoptosis.

Conclusion

Available preclinical evidence indicates that HCD induces caspase-dependent apoptosis through suppression of PI3K/Akt signaling and activation of both mitochondrial and death receptor pathways.

Future research

Further experimental and translational studies, including in vivo investigations and clinical validation, are required to determine the therapeutic potential of HCD in head and neck squamous cell carcinoma.

Author Biographies

Dr. Karthik Shunmugavelu, Assistant Professor, Department of Dentistry, PSP Medical College Hospital and Research Institute, Tambaram, Kanchipuram main roadOragadam Panruti, Kanchipuram district Tamilnadu 631604 India

is an Assistant Professor in the Department of Dentistry at PSP Medical College Hospital and Research Institute, Tamil Nadu, India. He holds BDS and MDS degrees in Oral and Maxillofacial Pathology and additional postgraduate qualifications from the United Kingdom. His academic interests include molecular oncology, apoptotic signaling pathways in head and neck malignancies, and translational cancer therapeutics.

Dr. Parthiban Nallaiyan (M.D.S), Assistant Professor, Government Medical College and Hospital, The Nilgiris.Tamilnadu India

is an Assistant Professor in Oral Pathology and Microbiology at Government Medical College and Hospital, The Nilgiris, Tamil Nadu, India. His research focuses on molecular mechanisms of oral carcinogenesis, biomarker discovery, and diagnostic pathology.

Uma Bharathi S, Undergraduate, PSP Medical College Hospital and research institute, Tambaram, Kanchipuram main roadOragadam Panruti, Kanchipuram district Tamilnadu 631604 India

is an undergraduate medical student at PSP Medical College Hospital and Research Institute. Her academic interests include oncology research, molecular medicine, and translational therapeutic strategies.

References

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3. Erratum in: Nat Rev Dis Primers. 2023 Jan 19;9(1):4. doi: 10.1038/s41572-023-00418-5. PMID: 33243986; PMCID: PMC7944998.

Farah CS. Molecular landscape of head and neck cancer and implications for therapy. Ann Transl Med. 2021 May;9(10):915. doi: 10.21037/atm-20-6264. PMID: 34164549; PMCID: PMC8184465.

Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, De Falco V, Upadhyay A, Kandimalla R, Chaudhary A, Dhanjal JK, Dewanjee S, Vallamkondu J, Pérez de la Lastra JM. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2022 Mar 18;10(4):1367-1401. https://doi.org/10.1016/j.gendis.2024.101211 PMid:38572324 PMCid:PMC10990713

Melo-Alvim C, Neves ME, Santos JL, Abrunhosa-Branquinho AN, Barroso T, Costa L, Ribeiro L. Radiotherapy, Chemotherapy and Immunotherapy-Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma. Diagnostics. 2023; 13(1):99. https://doi.org/10.3390/diagnostics13010099 PMid:36611391 PMCid:PMC9818309

Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol. 2009 Apr-May;45(4-5):324-34 https://doi.org/10.1016/j.oraloncology.2008.07.011 PMid:18805044 PMCid:PMC2743485

Shebbo S, Alateyah N, Yassin E, Mahmoud DES, Tamimi F, Anweigi L, Elhissi A, Abou-Saleh H, Elrayess MA, Agouni A. Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies and future considerations. Front Immunol. 2025 Aug 13;16:1626243. https://doi.org/10.3389/fimmu.2025.1626243 PMid:40881676 PMCid:PMC12380768

Glaviano, A., Foo, A.S.C., Lam, H.Y. et al. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22, 138 (2023). https://doi.org/10.1186/s12943-023-01827-6 PMid:37596643 PMCid:PMC10436543

Alqahtani A, Ayesh HSK, Halawani H. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis. Cancers (Basel). 2019 Dec 30;12(1):93. https://doi.org/10.3390/cancers12010093 PMid:31905960 PMCid:PMC7017171

Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K Pathway in Human Disease. Cell. 2017 Aug 10;170(4):605-635. https://doi.org/10.1016/j.cell.2017.07.029 PMid:28802037 PMCid:PMC5726441

Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127-50. https://doi.org/10.1146/annurev.pathol.4.110807.092311 PMid:18767981 PMCid:PMC2710138

Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Int J Mol Sci. 2021 Oct 14;22(20):11088. https://doi.org/10.3390/ijms222011088 PMid:34681745 PMCid:PMC8538152

Zhang X, Jin B, Huang C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets. 2007 Jun;7(4):305-16. https://doi.org/10.2174/156800907780809741 PMid:17979625

Castel P, Toska E, Engelman JA, Scaltriti M. The present and future of PI3K inhibitors for cancer therapy. Nat Cancer. 2021 Jun;2(6):587-597. https://doi.org/10.1038/s43018-021-00218-4 PMid:35118422 PMCid:PMC8809509

Mustafa M, Ahmad R, Tantry IQ, Ahmad W, Siddiqui S, Alam M, Abbas K, Moinuddin, Hassan MI, Habib S, Islam S. Apoptosis: A Comprehensive Overview of Signaling Pathways, Morphological Changes, and Physiological Significance and Therapeutic Implications. Cells. 2024 Nov 6;13(22):1838. https://doi.org/10.3390/cells13221838 PMid:39594587 PMCid:PMC11592877

Kelly GL, Strasser A. The essential role of evasion from cell death in cancer. Adv Cancer Res. 2011;111:39-96. https://doi.org/10.1016/B978-0-12-385524-4.00002-7 PMCid:PMC3128425

Kim R, Kin T, Beck WT. Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy. Cancers (Basel). 2024 Feb 28;16(5):984. https://doi.org/10.3390/cancers16050984 PMid:38473345 PMCid:PMC10930821

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018 Mar;25(3):486-541. https://doi.org/10.1038/s41418-017-0012-4 PMid:29362479 PMCid:PMC5864239

Sedlackova L, Korolchuk VI. Mitochondrial quality control as a key determinant of cell survival. Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):575-587. https://doi.org/10.1016/j.bbamcr.2018.12.012 PMid:30594496

Fouqué A, Legembre P. The CD95/CD95L Signaling Pathway: A Role in Carcinogenesis. Cancer Immunology. 2014 Aug 29:143-60. https://doi.org/10.1007/978-3-662-44006-3_9 PMCid: PMC7120825

McIlwain DR, Berger T, Mak TW. Caspases function in cell death and disease. Cold Spring Harb Perspect Biol. 2013 Apr 1;5(4):a008656. doi: 10.1101/cshperspect.a008656. Erratum in: Cold Spring Harb Perspect Biol. 2015 Apr 01;7(4):a026716. https://doi.org/10.1101/cshperspect.a026716 PMid:25833847 PMCid:PMC4382736

Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem. 2008 Jul 1;104(4):1124-49. https://doi.org/10.1002/jcb.21707 PMid:18459149 PMCid:PMC2941905

Acquaviva R, Malfa GA, Loizzo MR, Xiao J, Bianchi S, Tundis R. Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action. Molecules. 2022 Jul 26;27(15):4791. https://doi.org/10.3390/molecules27154791 PMid:35897965 PMCid:PMC9330018

Katkar KV, Suthar AC, Chauhan VS. The chemistry, pharmacologic and therapeutic applications of Polyalthia longifolia. Pharmacogn Rev. 2010 Jan;4(7):62-8. https://doi.org/10.4103/0973-7847.65329 PMid:22228943 PMCid:PMC3249904

Benson E, Li R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014 Jun;50(6):565-74. https://doi.org/10.1016/j.oraloncology.2013.09.008 PMid:24134947 PMCid:PMC4391706

Aguayo F, Pérez-Domínguez F, Osorio JC, Oliva C, Calaf GM. PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications. Biology (Basel). 2023 Apr 29;12(5):672. https://doi.org/10.3390/biology12050672 PMid:37237486 PMCid:PMC10215516

Ghiani L, Chiocca S. High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies. Int J Mol Sci. 2022 Mar 23;23(7):3483. https://doi.org/10.3390/ijms23073483 PMid:35408843 PMCid:PMC8998945

Giudice FS, Squarize CH. The determinants of head and neck cancer: Unmasking the PI3K pathway mutations. J Carcinog Mutagen. 2013 Aug 2;Suppl 5:003. https://doi.org/10.4172/2157-2518.S5-003 PMid:25126449 PMCid:PMC4130654

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021 Mar 29;372:n160. https://doi.org/10.1136/bmj.n160 PMid:33781993 PMCid:PMC8005925

Chan LP, Tseng YP, Wang HC, Chien CY, Wu CW, Wang LF, Yen TW, Wang PC, Liaw CC, Liang CH. The PI3K Inhibitor HCD Promotes Caspase Activation in Head and Neck Squamous Cells by Upregulating the Extrinsic and Intrinsic Apoptosis Pathways. J Oral Pathol Med. 2026 Jan;55(1):61-72. https://doi.org/10.1111/jop.70060 PMid:40953822 PMCid:PMC12774572

Chen YC, Wang PY, Huang BM, Chen YJ, Lee WC, Chen YC. 16-Hydroxycleroda-3,13-dien-15,16-olide Induces Apoptosis in Human Bladder Cancer Cells through Cell Cycle Arrest, Mitochondria ROS Overproduction and Inactivation of EGFR-Related Signalling Pathways. Molecules. 2020 Aug 30;25(17):3958. https://doi.org/10.3390/molecules25173958 PMid:32872665 PMCid:PMC7504739

Velmurugan BK, Wang PC, Weng CF. 16-Hydroxycleroda-3,13-dien-15,16-olide and N-Methyl-Actinodaphine Potentiate Tamoxifen-Induced Cell Death in Breast Cancer. Molecules. 2018 Aug 6;23(8):1966. https://doi.org/10.3390/molecules23081966 PMid:30082655 PMCid:PMC6222426

Cheng MF, Lin SR, Tseng FJ, Huang YC, Tsai MJ, Fu YS, Weng CF. The autophagic inhibition of oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide. Oncotarget. 2017 Jul 4;8(45):78379-78396. https://doi.org/10.18632/oncotarget.18987 PMid:29108236 PMCid:PMC5667969

Lin YH, Lee CC, Chan WL, Chang WH, Wu YC, Chang JG. 16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that are involved in cancer cell apoptosis. Toxicology. 2011 Jul 11;285(1-2):72-80. https://doi.org/10.1016/j.tox.2011.04.004 PMid:21530604

Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998 Aug 28;281(5381):1309-12. https://doi.org/10.1126/science.281.5381.1309 PMid:9721092

Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007 Jun;35(4):495-516. https://doi.org/10.1080/01926230701320337 PMid:17562483 PMCid:PMC2117903

Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993 Aug 27;74(4):609-19. https://doi.org/10.1016/0092-8674(93)90509-O PMid:8358790

Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002 Sep;2(9):647-56. https://doi.org/10.1038/nrc883 PMid:12209154

Simon HU, Haj-Yehia A, Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000 Nov;5(5):415-8. https://doi.org/10.1023/A:1009616228304 PMid:11256882

Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009 Jul;8(7):579-91. https://doi.org/10.1038/nrd2803 PMid:19478820

Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007 May;12(5):913-22. https://doi.org/10.1007/s10495-007-0756-2 PMid:17453160

Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010 Mar 15;48(6):749-62. https://doi.org/10.1016/j.freeradbiomed.2009.12.022 PMid:20045723 PMCid:PMC2823977

Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997 Oct 17;91(2):231-41. https://doi.org/10.1016/S0092-8674(00)80405-5 PMid:9346240

Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998 Nov 13;282(5392):1318-21. https://doi.org/10.1126/science.282.5392.1318 PMid:9812896

Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007 Jun 29;129(7):1261-74. https://doi.org/10.1016/j.cell.2007.06.009 PMid:17604717 PMCid:PMC2756685

Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82. https://doi.org/10.1038/nature14129PMid:25631445 PMCid: PMC4311405

Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, Freilino M, Sauerwein S, Peyser ND, Xiao D, Diergaarde B, Wang L, Chiosea S, Seethala R, Johnson JT, Kim S, Duvvuri U, Ferris RL, Romkes M, Nukui T, Kwok-Shing Ng P, Garraway LA, Hammerman PS, Mills GB, Grandis JR. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013 Jul;3(7):761-9 https://doi.org/10.1158/2159-8290.CD-13-0103 PMid:23619167 PMCid:PMC3710532

Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, Carter SL, Voet D, Cortés ML, Auclair D, Berger MF, Saksena G, Guiducci C, Onofrio RC, Parkin M, Romkes M, Weissfeld JL, Seethala RR, Wang L, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Winckler W, Ardlie K, Gabriel SB, Meyerson M, Lander ES, Getz G, Golub TR, Garraway LA, Grandis JR. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011 Aug 26;333(6046):1157-60. https://doi.org/10.1126/science.1208130 PMid:21798893 PMCid:PMC3415217

Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011 Aug 26;333(6046):1154-7. https://doi.org/10.1126/science.1206923 PMid:21798897 PMCid:PMC3162986

Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008 Jan 11;132(1):27-42. https://doi.org/10.1016/j.cell.2007.12.018 PMid:18191218 PMCid:PMC2696814

Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52. https://doi.org/10.1038/nrm2239 PMid:17717517 PMCid:PMC11627063

Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007 Jan;87(1):99-163. https://doi.org/10.1152/physrev.00013.2006 PMid:17237344

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74. https://doi.org/10.1016/j.cell.2011.02.013 PMid:21376230

Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998 Aug 28;281(5381):1305-8. https://doi.org/10.1126/science.281.5381.1305 PMid:9721089

Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003 Jan;10(1):26-35. https://doi.org/10.1038/sj.cdd.4401186 PMid:12655293

Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995 Nov 15;14(22):5579-88. https://doi.org/10.1002/j.1460-2075.1995.tb00245.x PMid:8521815 PMCid:PMC394672

Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998 Aug 21;94(4):491-501. https://doi.org/10.1016/S0092-8674(00)81590-1 PMid:9727492

Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998 Aug 21;94(4):481-90. https://doi.org/10.1016/S0092-8674(00)81589-5 PMid:9727491

Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res. 1999 Oct 15;59(20):5356-64. PMID: 10537320.